XML 101 R41.htm IDEA: XBRL DOCUMENT v3.22.4
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2022
Summary of information about stock options under the Plan

    

    

    

Weighted

    

 

Weighted

Average

 

Average

Remaining

 

Number of

Exercise

Contractual

Intrinsic

 

Shares

Price

Life (Years)

Value

 

(in thousands, except per share and year data)

 

Balance at December 31, 2019

 

527

$

20.02

 

3.0

$

364

Granted

 

510

12.24

Exercised

 

(14)

10.20

10

Forfeited

(197)

21.79

2

Expired

(125)

11.85

Balance at December 31, 2020

 

701

$

15.51

 

4.2

$

53

Granted

 

95

12.21

Exercised

 

10

Forfeited

 

(159)

14.56

2

Expired

 

(20)

71.00

Balance at December 31, 2021

 

617

$

13.43

 

4.2

$

53

Forfeited

 

(159)

12.27

2

Expired

(10)

27.80

Balance at December 31, 2022

 

448

$

13.43

 

2.6

$

Exercisable at December 31, 2022

 

321

$

13.81

 

2.6

$

Schedule of weighted-average assumptions used for estimation of the fair value of the options granted under the Plan at the date of grant, using the Black-Scholes Option Valuation Model

2022

    

2021

    

2020

Risk-free interest rate

-

0.519% to 0.873%

0.157% to 0.322%

Dividend yield

-

0.00%

0.00%

Volatility factor of the expected market price of common stock

-

63%

59%

Weighted-average expected life of option

-

3.5 years

3.5 years

Weighted-average grant date fair value

-

$

1.22

$

1.22

Summary of status and activity of non-vested stock options

Weighted Average

Grant Date

Number of

Fair Value

    

Shares

    

Per Share

(in thousands, except per share amounts)

Non-vested, beginning of year

390

$

4.26

Granted

$

-

Cancelled/Forfeited

(99)

$

4.16

Vested

(165)

$

4.40

Non-vested, end of year

126

$

4.15

November 2019 Offering  
Schedule of Black-Scholes pricing model to determine the fair value of warrants

November 20, 2019

Risk-free interest rate

1.55

%

Dividend yield

0.00

%

Volatility factor of the expected market price of common stock

60

%

Weighted-average expected life

5 years

Weighted-average grant date fair value

$

0.52